$4.17
Drug delivery company Nutriband is conducting an offering of units comprised of one share of common stock and one warrant exercisable for one share of common stock.
The offering is contingent upon the approval of Nutriband's application for listing on the Nasdaq under the ticker symbol NTRB.
The stock is currently listed on the Over-the-Counter Markets under the same symbol.
Our top picks for where to buy Nutriband stock
How to buy Nutriband stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NTRB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Nutriband stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Nutriband stock price (NASDAQ: NTRB)
Use our graph to track the performance of NTRB stocks over time.Nutriband shares at a glance
Latest market close | $4.26 |
---|---|
52-week range | $1.53 - $9.60 |
50-day moving average | $6.00 |
200-day moving average | $4.00 |
Wall St. target price | $18.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.77 |
Is it a good time to buy Nutriband stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Nutriband price performance over time
Historical closes compared with the close of $4.26 from 2024-09-04
1 week (2024-08-30) | 4.41% |
---|---|
1 month (2024-08-06) | -14.29% |
3 months (2024-06-06) | -20.22% |
6 months (2024-03-06) | 80.51% |
1 year (2023-09-06) | 32.30% |
---|---|
2 years (2022-09-06) | 4.41% |
3 years (2021-09-03) | 10 |
5 years (2019-09-05) | 23.1429 |
Nutriband financials
Revenue TTM | $2 million |
---|---|
Gross profit TTM | $750,409 |
Return on assets TTM | -30.13% |
Return on equity TTM | -60.41% |
Profit margin | 0% |
Book value | $1.22 |
Market Capitalization | $45.3 million |
TTM: trailing 12 months
Nutriband share dividends
We're not expecting Nutriband to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (5.79% forward annual dividend yield)
Have Nutriband's shares ever split?
Nutriband's shares were split on a 1166:1000 basis on 11 August 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1166 shares. This wouldn't directly have changed the overall worth of your Nutriband shares – just the quantity. However, indirectly, the new 14.2% lower share price could have impacted the market appetite for Nutriband shares which in turn could have impacted Nutriband's share price.
Nutriband share price volatility
Over the last 12 months, Nutriband's shares have ranged in value from as little as $1.53 up to $9.595. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nutriband's is 0.416. This would suggest that Nutriband's shares are less volatile than average (for this exchange).
To put Nutriband's beta into context you can compare it against those of similar companies.
- BioNTech (BNTX.US): 0.233
- Moderna (MRNA.US): 1.662
- Pfizer (PFE.US): 0.633
Nutriband overview
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida. .
Frequently asked questions
What percentage of Nutriband is owned by insiders or institutions?Currently 54.005% of Nutriband shares are held by insiders and 2.379% by institutions. When does the fiscal year end for Nutriband?
Nutriband's fiscal year ends in January. Where is Nutriband based?
Nutriband's address is: 121 South Orange Avenue, Orlando, FL, United States, 32801 What is Nutriband's ISIN number?
Nutriband's international securities identification number is: US67092M2089 What is Nutriband's CUSIP number?
Nutriband's Committee on Uniform Securities Identification Procedures number is: 67092M208
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question